Targeting Free Light Chain (FLC) secretion and the unfolded protein response in myeloma cells using van, a combination of repurposed drugs

Documenti analoghi

• Progression free survival of myeloma patients who become IFE-negative correlates with the detection of residual monoclonal free light chain (FLC) by mass spectrometry
  di: H. V. Giles, et al.
  Pubblicazione: (2024-03-01)
• Aggressive FLC Escape in a Patient with IgD Myeloma
  di: Cédric Farges, et al.
  Pubblicazione: (2015-01-01)
• Does the pursuit of scientific excellence serve or hamper translational medical research: an historical perspective from hematological malignancies
  di: Chris M. Bunce, et al.
  Pubblicazione: (2022-10-01)
• APF Applied on PV Conversion Chain Network Using FLC
  di: Bourourou Fares, et al.
  Pubblicazione: (2023-04-01)
• P879: EXENT AND FLC MASS SPECTROMETRY FOR SEROLOGICAL IDENTIFICATION AND QUANTIFICATION OF MONOCLONAL IMMUNOGLOBULINS IN MULTIPLE MYELOMA
  di: S. Huhn, et al.
  Pubblicazione: (2022-06-01)